Action on Antimicrobial resistance in EU/EEA Members States: Good progress but more to do.
The
Commission today published a report prepared by the University of
Bordeaux on the implementation of the Council recommendation of 15
November 2001 (2002/77/EC) on the prudent use of antimicrobial agents in
human medicine. The report is based on questionnaires completed by EU
and EEA Member States in 2015, which were analysed by the Bordeaux
researchers.
20 out of the 29 countries providing information for the report
had defined a strategy to promote prudent use of antimicrobial agents
and contain antimicrobial resistance; six reported that they were in the
process of developing strategies and /or actions plans and 3 had
neither an AMR strategy nor a plan to create one.
In most countries action plans included measures regarding
surveillance, prudent use of antimicrobial agents, information and
education. Detection and control of outbreaks, research and the use of
rapid diagnostic tests (RDTs) were also commonly included. Nursing homes
and long term care facilities were covered by 14 out of the 21 action
plans.
The Recommendation (2002/77/EC) aims to address the threat of
antimicrobial resistance (AMR) and asks Member States to develop
strategies comprising measures in relation to surveillance, education,
information, prevention and control, and research. The report published
today will feed into work on establishing new EU initiatives to take
forward EU action against the rising threat from antimicrobial
resistance.
Download the report
For further information see:
Meta proves AI hype has its limits
-
Artificial intelligence is a multibillion-dollar project with no clear
timeline for revenues
2 ore fa
Post
Nessun commento:
Posta un commento